Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × tesetaxel × Clear all

NCT03952325 2021-07-30

CONTESSA TRIO

Phase 2 Terminated

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms